Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
novartis glp-1 receptor agonist Agonists as Treatments for Type 2 Diabetes The benefits of GLP1 Size:1 Pack reduce body fat
The benefits of GLP1 receptors in cardiovascular diseases - PMC
What this analysis does not include: Medical advice, treatment recommendations, or product endorsements
reduce body fat
Size:1 Pack
Introduction Type 2 diabetes mellitus (T2DM) is a growing global public health challenge, with its rising prevalence imposing substantial burdens on healthcare systems worldwide.1 Beyond the well-documented metabolic complications, T2DM significantly increases the risk of cognitive impairment and dementia, particularly Alzheimer’s disease (AD), and other non-vascular dementias (non-VaDs).2 These conditions drastically reduce patients’ quality of life and create immense economic strain on families, healthcare systems, and societies.2 3 Epidemiological studies indicate that individuals with T2DM have a 1.7-fold higher risk of developing dementia compared with the general population.4 With the aging population further exacerbating this issue, preventing T2DM-related dementia has become an urgent priority for public health
